Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 611-207-6 | CAS number: 5488-51-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20-Jan-1992 t0 13-May-1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant and preformed in accordance with EEC-Directive 84-449, Annex V, Part B 1.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: EEC-Directive 84-449, Annex V, Part B 1
- Deviations:
- yes
- Remarks:
- Temperatured was lower on days -1, 0 and 3. There was a power failure one day before the end of the study. None of these deviations are considered to have affected the integrity of the study.
- Qualifier:
- according to guideline
- Guideline:
- other: Solvay Duphar standard operating procedure TDS 026
- Deviations:
- yes
- Remarks:
- Temperature >18 but <19 was observed on days -1, 0 and 3 of the study. Power failure resulted in the light being switched on one hour later on the final day of the study.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- (9R,10S,13S)-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]
- EC Number:
- 611-207-6
- Cas Number:
- 5488-51-7
- Molecular formula:
- C25H36O4
- IUPAC Name:
- (9R,10S,13S)-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]
- Test material form:
- other: Solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals
SPF-derived Hsd/Cpb:WU Wistar rats were obtained from Harlan/CPS, Zeist, The Netherlands. Male rats weighed 175-200 g and females 150-175 g at arrival.
Animal care
The rats were housed continuously in Macrolon cages with two or three animals per cage. The rats had free access to food (a standard laboratory diet RHM-TM, Hope Farms, Woerden, The Netherlands), except for a period of about 18 hours prior to dosing until 6 hours after dosing. Water was available ad libitum. The acclimatisation period was 5 days. Animals were housed in room no. 408, CDA IV, with the following animal room conditions:
Temperature: 18-25°C
Relative humidity: 48-70%
Artificial light: from 7 a.m. till 7 p.m
Radio-sound: 24 hours per day
Ventilation: approximately 16 air changes per hour.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 1.25% tragacanth solution in distilled water
- Details on oral exposure:
- - Concentration in vehicle: Retroketal, a white solid material, was suspended in a 1.25% tragacanth solution in distilled water. The final concentration was 0.2 g/ml. The actual concentration and the stability of retroketal in the vehicle were not checked using analytical methods, but the test suspension was used immediately after preparation.
- Lot/batch no.: RK149A3
- Purity: 87.4%
Dose selection was a single oral dose of 2000 mg/kg. - Doses:
- Single oral dose of 2000 mg/kg
- No. of animals per sex per dose:
- 5/sex/group
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were weighed one day before dosing, at the day of dosing and at 2, 7 and 14 days after treatment. Any sign of intoxication occurring during the 14-day observation period was recorded. Gross post-mortem examination was done on all rats at the end of the 14-day observation period.
Clinical signs
The rats were observed from 0-0.5 hour and at 1.5, 3, 6 and 27 hours after application and thereafter once on each day till the end of the experiment. Any sign of intoxication which could be ascertained by observation and manipulation of the rats during the 14-day observation period was recorded.
Autopsy
At the end of the experiment, the rats were killed by ether inhalation and an autopsy was performed that included inspection of the external appearance, the cervical area, the thoracic and abdominal cavities.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None of the animals died after a single oral dose of 2000 mg/kg of retroketal. Decreased locomotor activity, decreased respiratory rate, abnormal gait and posture were observed in males, but not in females. The time of onset of the first signs was between 0.5 and 1.5 hours. Signs were slight in intensity and had disappeared by 27 hours.
- Clinical signs:
- other: The clinical signs observed in males were mostly indicative of effects on motor coordination (decreased locomotor activity, abnormal gait and posture). In female rats no clinical signs were observed.
- Gross pathology:
- At autopsy 14 days after dosing no abnormalities were noted for any male animal. One female rat showed a dilated uterus. Dilatation of the uterus is considered to be a physiological process within the oestrus cycle, which is routinely noticed in approximately 1 out of 5 female animals. Therefore, this finding was considered not to be treatment-related.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Oral administration of a single dose of 2000 mg/kg of retroketal caused no mortalities among male and female rats during the 14-day observation period. Therefore, the 14-day oral LD50 is greater than 2000 mg/kg in rats.
The clinical signs observed in males were mostly indicative of effects on motor coordination (decreased locomotor activity, abnormal gait and posture). In female rats no clinical signs were observed.
A single oral dose of 2000 mg/kg of retroketal had no effect on mean body weight-gains of male and female rats.
At autopsy, no treatment-related abnormalities were seen in male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.